PROV:NASDAQProvident Financial Holdings, Inc. Analysis
Data as of 2026-04-25 - not real-time
$17.01
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
PROV is trading just above its 20‑day SMA, indicating short‑term bullish momentum. The 14‑day RSI sits in the upper‑mid range, supporting continued buying pressure without being overbought. However, the MACD has turned slightly bearish, with the line below the signal and a small negative histogram, hinting at a possible near‑term pullback. The stock is priced near the upper end of its recent range, just below the 52‑week high and close to the identified resistance at $17.35. Volume has been trending down, which may limit upside and increase the risk of a breakout failure. The balance sheet carries $215 M of debt against $54 M of cash, a leverage profile typical for regional banks but worth monitoring.
Valuation metrics show a price‑to‑book of 0.86 and a forward P/E of 13, both comfortably below industry averages, suggesting the shares are undervalued on a fundamental basis. The dividend yield of 3.3% with a payout ratio around 56% provides an attractive income component. Operating margins are healthy at 24% and profit margin exceeds 16%, while revenue grew roughly 11% year‑over‑year. Return on equity is modest at about 5%, reflecting the bank’s conservative asset base. The low beta of 0.37 and modest 30‑day volatility point to limited market‑wide price swings. Overall, the combination of solid fundamentals, attractive dividend, and modest downside risk supports a cautiously optimistic stance, with attention to the near‑term technical resistance.
Valuation metrics show a price‑to‑book of 0.86 and a forward P/E of 13, both comfortably below industry averages, suggesting the shares are undervalued on a fundamental basis. The dividend yield of 3.3% with a payout ratio around 56% provides an attractive income component. Operating margins are healthy at 24% and profit margin exceeds 16%, while revenue grew roughly 11% year‑over‑year. Return on equity is modest at about 5%, reflecting the bank’s conservative asset base. The low beta of 0.37 and modest 30‑day volatility point to limited market‑wide price swings. Overall, the combination of solid fundamentals, attractive dividend, and modest downside risk supports a cautiously optimistic stance, with attention to the near‑term technical resistance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance at $17.35
- Bearish MACD crossover
- Decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued price‑to‑book and forward P/E
- Attractive 3.3% dividend yield
- Revenue growth of ~11% YoY
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low beta indicating limited market volatility
- Sustainable dividend payout
- Discounted valuation relative to book value
Key Metrics & Analysis
Financial Health
Revenue Growth10.90%
Profit Margin16.17%
P/E Ratio17.2
ROE5.15%
ROA0.53%
P/B Ratio0.9
Op. Cash Flow$9.5M
Industry P/E17.3
Technical Analysis
TrendBullish
RSI65.7
Support$15.81
Resistance$17.35
MA 20$16.79
MA 50$16.37
MA 200$15.84
MACDBearish
VolumeDecreasing
Fear & Greed Index88.02
Valuation
Target Price$16.00
Upside/Downside-5.94%
GradeUndervalued
TypeBlend
Dividend Yield3.28%
Risk Assessment
Beta0.37
Volatility11.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.